What is Paramesu Biotech IPO?

Paramesu Biotech IPO is a Mainboard IPO having an issue size of Rs. ₹600 Crs. It is priced at ₹0.00 - ₹0.00 per share. The issue opens on 27 Jul 2026 and closes on 27 Jul 2026.

When will Paramesu Biotech IPO open?

Paramesu Biotech IPO opens on 27 Jul 2026 and closes on 27 Jul 2026.

What is the GMP of Paramesu Biotech IPO?

The estimated Grey Market Premium of Paramesu Biotech IPO is ₹0 per share (-).

What is the lot size of Paramesu Biotech IPO?

The minimum lot size of Paramesu Biotech IPO is 0.00 shares and the minimum application amount is Rs. 0.

When is the allotment of Paramesu Biotech IPO?

The allotment date of Paramesu Biotech IPO is 27 Jul 2026.

What is the listing date of Paramesu Biotech IPO?

The listing date of Paramesu Biotech IPO is 27 Jul 2026.

What is the subscription of Paramesu Biotech IPO?

Paramesu Biotech IPO subscription details are available on the IPO360 company page.

What is the price band of Paramesu Biotech IPO?

Paramesu Biotech IPO is priced at ₹0.00 - ₹0.00 per share.

How to check allotment status of Paramesu Biotech IPO?

You can check the allotment status from the allotment link available on the Paramesu Biotech IPO page on IPO360.

How to apply Paramesu Biotech IPO in Zerodha?

You can apply through the Zerodha Kite app by navigating to Bids → IPO, selecting the IPO, entering bid details and approving the UPI mandate.

How to apply Paramesu Biotech IPO in Groww?

You can apply through the Groww app by going to Stocks → IPO, selecting the IPO, entering bid details and approving the UPI mandate.

How to apply Paramesu Biotech IPO using ASBA?

You can apply via ASBA by logging into your bank's net banking portal, selecting the IPO under ASBA, entering bid details and submitting the application.

Paramesu Biotech Limited IPO

Mainboard NSE & BSE

Paramesu Biotech Limited IPO

Mainboard NSE & BSE 100% Book Built Offer

Website DRHP

Business Overview

Paramesu Biotech Limited is among India’s largest manufacturers of maize-based speciality products for food, animal nutrition, paper, and other industrial uses (F&S Report). Its diversified portfolio includes native and modified maize starches, liquid glucose, maltodextrin powder, and co-products such as germs, gluten, fiber, corn steep liquor, and enriched fiber, catering to a wide range of industries and applications.

Lots & IPO Size

Paramesu Biotech IPO Size

Fresh Issue

₹520 Cr (TBA Shares)

Offer For Sale

₹80 Cr (TBA Shares)

Objects of Issue

Funding the capex requirement for setting up of new plant
Repayment in part or full, of certain borrowings availed by our Company
General Corporate Purposes

Paramesu Biotech IPO Financial Performance

(Rs. in crores)

Financial Performance Metrics for Paramesu Biotech IPO
Particulars	Sep-24	Mar-24	Mar-23	Mar-22
Revenue from Operations	407.59	627.85	623.93	494.91
Profit after Tax	26.85	40.34	32.52	33.97
Net Worth	200.10	173.12	132.96	100.95
Total Borrowing	216.18	205.88	140.56	81.98
Total Assets	479.44	439.68	319.17	238.88
NAV per share (in ₹)	7.62	6.59	5.06	3.84
EPS - Basic (in ₹)	1.02	1.54	1.24	1.29